在严重的喘模型中,N-cadherin对抗作用是支气管保护性的
Nicolas L Pereira1, Niccole Schaible2, Abhishek Desai1
1Lung and Vascular Inflammation Section, Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Science advances
|November 29, 2024
概括
在呼吸道光滑肌细胞中发现的蛋白质N-cadherin驱动严重的喘症状. 通过ADH-1抑制N-cadherin提供了一种潜在的新疗法,可以减少气道收缩并改善喘治疗.
科学领域:
- 肺部医学 肺部医学
- 细胞生物学 细胞生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 严重的喘的特点是难以治愈的气道阻塞和残疾.
- 目前用于严重喘的治疗方法,包括皮质类固醇和支气管扩展剂,往往是无效的.
- 过度的呼吸道光滑肌肉 (ASM) 收缩到发作是喘病理学的关键因素.
研究的目的:
- 为了研究N-cadherin在严重喘中的作用.
- 评估ADH-1作为抑制ASM高反应性和支气管收缩的潜在治疗剂.
主要方法:
- 从严重喘患者的ASM中检查了N-cadherin表达.
- 利用过敏气道炎症的小鼠模型来评估气道阻塞.
- 用ADH-1来抑制N-cadherin,并评估其对呼吸道过敏反应,支气管收缩和支气管扩张的作用.
主要成果:
- 在严重喘患者的ASM中,N-cadherin被上调,并且在小鼠模型中需要用于呼吸道阻塞.
- 治疗ADH-1减少了无关过敏炎症的呼吸道过敏反应.
- 通过破坏N-cadherin-δ-catenin相互作用和减少actin重塑,ADH-1可以防止支气管收缩,并促进支气管扩张ex vivo.
结论:
- 在严重喘中,N-cadherin在调解ASM收缩和呼吸道阻塞方面发挥着关键作用.
- N-cadherin代表了一个有前途的治疗点,用于开发新型治疗来抑制喘中的支气管收缩.
- 通过向N-cadherin,ADH-1显示出作为一种治疗严重喘的药物的潜力.
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
237
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
237
01:20Asthma: Pathogenesis and Management
351
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
351
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
233
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
233
01:26Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
01:26COPD: Management Using Bronchodilators and Corticosteroids
179
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
179